Taking place in London in September, this event will bring together the ecosystem of the advanced therapies’ industry to promote the opportunities provided by the European market. With 350 attendees and 80-plus speakers from 18 countries as well as 32 exhibitors in attendance, this event will focus on meeting the challenges of managing advanced therapy medicinal products (ATMPs) in this dynamic region. The event is tailored to a European audience looking to commercialise ATMPs as well as a global audience interested in entering the European market.
The conference is ideally suited for early and late-stage biotechs; pharma; investors and analysts; solution and tech providers; academia; regulators and payers; and clinicians.
To find out about confirmed speakers, view the three-track agenda and register a place, please visit www.phacilitate-leaders-europe.com.